Completed NA INTERVENTIONAL 1-arm NCT05153122

A Feasibility Study of Wearable Device in Assessing Respiratory Condition Change of Patients With Exacerbation of COPD

A Feasibility Study of Evaluation of SenseGuard, Non-Invasive Wearable Device, in Assessing Respiratory Condition Change of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease

Sponsor: NanoVation

Conditions COPD Exacerbation

Interventions SenseGuard

Updated 5 times since 2022 Last updated: Mar 24, 2024 Started: Aug 11, 2020 Primary completion: May 25, 2022 Completion: May 25, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on COPD Exacerbation, this trial is completed. The trial is conducted by NanoVation and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2022 — Apr 2024 [monthly]

Recruiting NA
Jan 2022 — Apr 2022 [monthly]

Recruiting NA

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NanoVation

Data source: NanoVation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halle, Germany
• Nahariya, Israel